For more
Scientific References please see individual product pages.
Metadichol Research:
Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro
Research published by Dr. Palayakotai Raghavan
https://thenanosoma.com/published-articles?aff_id=4751
United States Patent 8,722,093 B2:
A method of increasing serum vitamin C level in a subject
A method of inhibiting NF-kB protein level in a subject
A method of increasing adiponectin level in a subject
A method of reducing TNF alpha level in a subject
United States Patent 9,006,292 B2:
A method of treating a skin disease in a subject, comprising: psoriasis, atopic dermatitis, contact dermatitis and other eczematous dermatitis, seborrheic dermatitis, neurodermatitis, decubitus, lichen planus, pemphigus, bullate pemphigoid, epidermolysis bullosa, urticaria, angio-edemas, vasculitis, erythema, cutaneous, eosinophilias, lupus erythematosus, eczema, MRSA, and basal cell carcinoma.
A method of treating a disease by improving a physiologic or metabolic parameter in a subject.
The said method comprising: Increasing serum APO A1 protein, hemoglobin, platelet count; Reducing lipoprotein-a, uric acid, elevated AST:ALT ratio, ferritin, bilirubin, PTH, calcium, creatinine, alkaline phosphatase, BUN, phosphorus levels; Regulating eGFR level, neutrophils, monocytes, white blood cell, thyroid hormone (TSH).
The method of claim wherein said disease is: kidney disease, MRSA infection, MDS, hematological disease, prostate cancer, and eczema.
United States Patent 9,034,383 B2:
The present invention provides nanoparticulate policosanol, and octacosanol formulations including these particles, as well as methods of using the particles and formulations for treatment and prophylaxis of various diseases and conditions.
